• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationships between the haemolytic activities of the human complement system and complement components.人类补体系统的溶血活性与补体成分之间的关系。
Clin Exp Immunol. 1979 Feb;35(2):324-8.
2
Plasma levels of complement components and complement haemolytic activity in protein-energy malnutrition.蛋白质-能量营养不良时补体成分的血浆水平及补体溶血活性
Clin Exp Immunol. 1978 Nov;34(2):248-52.
3
Preanalytical classical and alternative complement pathway activity loss.分析前经典和替代补体途径活性丧失。
Biochem Med (Zagreb). 2019 Oct 15;29(3):030701. doi: 10.11613/BM.2019.030701. Epub 2019 Aug 5.
4
[Compliment system proteins: properties and biological activity (Lecture)].补体系统蛋白:特性与生物活性(讲座)
Klin Lab Diagn. 2000 Jul(7):25-32.
5
Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction.炎症反应中补体、激肽、凝血和纤溶系统之间的关系。
Clin Physiol Biochem. 1983;1(2-5):225-84.
6
Complement in tears from normal humans.正常人泪液中的补体。
Am J Ophthalmol. 1979 Oct;88(4):758-63. doi: 10.1016/0002-9394(79)90679-2.
7
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.细菌对补体介导杀伤作用的抗性机制研究。VI. IgG通过在C5裂解前的一个步骤发挥作用,提高C5b-9对大肠杆菌0111B4的杀菌效率。
J Immunol. 1983 Nov;131(5):2570-5.
8
Flavonol glycosides and other phenolic compounds from Viola tianshanica and their anti-complement activities.天山堇菜中的黄酮醇苷及其他酚类化合物及其抗补体活性。
Pharm Biol. 2016 Jul;54(7):1140-7. doi: 10.3109/13880209.2015.1055635. Epub 2015 Jun 17.
9
C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.通过经典补体途径在分离的补体成分反应混合物中形成C56。
Int Arch Allergy Appl Immunol. 1985;78(1):101-7. doi: 10.1159/000233870.
10
Haemolytic complement in peripheral lymph of normal men.正常男性外周淋巴中的溶血补体。
Clin Exp Immunol. 1978 Jun;32(3):392-8.

引用本文的文献

1
Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation.实体器官移植中预测感染风险的临床免疫监测策略。
Clin Transl Immunology. 2014 Feb 28;3(2):e12. doi: 10.1038/cti.2014.3. eCollection 2014 Feb.
2
Familial C1q deficiency associated with renal and cutaneous disease.与肾脏和皮肤疾病相关的家族性C1q缺乏症。
Clin Exp Immunol. 1981 Apr;44(1):173-80.
3
Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.系统性红斑狼疮患者替代途径及B因子溶血活性的评估:与替代途径调节蛋白的相关性
Clin Exp Immunol. 1980 Dec;42(3):495-505.
4
Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.脂多糖在铜绿假单胞菌调理作用和吞噬作用中的作用。
Infect Immun. 1985 Jul;49(1):182-9. doi: 10.1128/iai.49.1.182-189.1985.

本文引用的文献

1
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.备解素系统与免疫。I. 一种新的血清蛋白——备解素的证实、分离及其在免疫现象中的作用。
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.
2
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.豚鼠血清中溶血补体九种成分的分离、纯化及测定方法
Immunochemistry. 1966 Mar;3(2):111-35. doi: 10.1016/0019-2791(66)90292-8.
3
The separation of nine components and two inactivators of components of complement in humansserum.人血清中补体九个成分及两个补体成分灭活剂的分离
Immunochemistry. 1970 Jan;7(1):43-61. doi: 10.1016/0019-2791(70)90029-7.
4
Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.眼镜蛇毒中抗补体蛋白的分离及其对C3的作用方式。
J Immunol. 1971 Dec;107(6):1666-72.
5
Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.眼镜蛇毒中的两种抗补体因子:其中一种可使豚鼠红细胞发生溶血。
J Immunol. 1969 Nov;103(5):944-52.
6
Enharncement of the hemolytic activity of the second component of human complement by oxidation.通过氧化增强人补体第二成分的溶血活性。
J Exp Med. 1967 Dec 1;126(6):1013-25. doi: 10.1084/jem.126.6.1013.
7
Studies of the C3 shunt activation in cobra venom induced lysis of unsensitized erythrocytes.眼镜蛇毒诱导未致敏红细胞溶解过程中C3旁路激活的研究。
Proc Soc Exp Biol Med. 1972 Jul;140(3):1116-21. doi: 10.3181/00379727-140-36623.
8
Activation of the alternate pathway of human complements by rabbit cells.兔细胞对人补体替代途径的激活。
J Immunol. 1974 Jul;113(1):348-58.
9
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.补体激活替代途径中B因子和D因子的溶血扩散平板试验。
Immunochemistry. 1976 Apr;13(4):317-24. doi: 10.1016/0019-2791(76)90341-4.
10
Presidential address to the American Association of Immunologists, delivered in Chicago, Illinois, April 6, 1977. Mechanism of cytolysis by lymphocytes: A comparison with complement.1977年4月6日于伊利诺伊州芝加哥市发表的美国免疫学家协会主席演讲。淋巴细胞的细胞溶解机制:与补体的比较。
J Immunol. 1977 Oct;119(4):1195-203.

人类补体系统的溶血活性与补体成分之间的关系。

Relationships between the haemolytic activities of the human complement system and complement components.

作者信息

Takada A, Imamura Y, Takada Y

出版信息

Clin Exp Immunol. 1979 Feb;35(2):324-8.

PMID:436337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1537652/
Abstract

The relationships between the haemolytic activities of complement and its components were studied. The activities studied included CH50 (classical pathway), AP50 (alternative pathway), CV50 (early part of alternative pathway) and C(3--9)H50 ((the late part of both pathways). The components included C3, C4, C5, C9, B and D. There was a good correlation between CH50 and AP50. AP50 had a good correlation with B and CV50. There was no correlation between AP50 and C(3--9)H50, and none between C(3--9)H50 and C5 or C9. AP50 may primarily represent changes in the early part of the alternative pathway. C(3--9)H50 is not influenced by respective changes in the amounts of C5 or C9. Since cell lesion is now considered to be caused by a unit of C5b to C9, a change in each component of C5 to C9 may not influence haemolytic activity.

摘要

对补体及其各成分的溶血活性之间的关系进行了研究。所研究的活性包括CH50(经典途径)、AP50(替代途径)、CV50(替代途径早期部分)和C(3--9)H50(两条途径的晚期部分)。所涉及的成分包括C3、C4、C5、C9、B和D。CH50与AP50之间存在良好的相关性。AP50与B和CV50具有良好的相关性。AP50与C(3--9)H50之间无相关性,C(3--9)H50与C5或C9之间也无相关性。AP50可能主要代表替代途径早期部分的变化。C(3--9)H50不受C5或C9各自量的变化影响。由于现在认为细胞损伤是由C5b至C9的一个单位引起的,C5至C9各成分的变化可能不会影响溶血活性。